Furthermore, we found that RA and other invasive procedures had similar risks for short-term MACEs, mortality, TVR, slow/no flow, stent thrombosis, in-stent restenosis, heart failure, stroke, emergency CABG, contrast volume, and inflammation (i.e., Interleukin-6). The gene discussed is IL6; the disease is heart failure.